Literature DB >> 31736441

Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma/Leukemia in NSG Mice.

Heather Tillman1, Laura J Janke1, Amy Funk2, Peter Vogel1, Jerold E Rehg1.   

Abstract

The NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ strain (NOD scid gamma, NSG) is a severely immunodeficient inbred laboratory mouse used for preclinical studies because it is amenable to engraftment with human cells. Combining scid and Il2rgnull mutations results in severe immunodeficiency by impairing the maturation, survival, and functionality of interleukin 2-dependent immune cells, including T, B, and natural killer lymphocytes. While NSG mice are reportedly resistant to developing spontaneous lymphomas/leukemias, there are reports of hematopoietic cancers developing. In this study, we characterized the immunophenotype of spontaneous lymphoma/leukemia in 12 NSG mice (20 to 38 weeks old). The mice had a combination of grossly enlarged thymus, spleen, or lymph nodes and variable histologic involvement of the bone marrow and other tissues. All 12 lymphomas were diffusely CD3, TDT, and CD4 positive, and 11 of 12 were also positive for CD8, which together was consistent with precursor T-cell lymphoblastic lymphoma/leukemia (pre-T-LBL). A subset of NSG tissues from all mice and neoplastic lymphocytes from 8 of 12 cases had strong immunoreactivity for retroviral p30 core protein, suggesting an association with a viral infection. These data highlight that NSG mice may develop T-cell lymphoma at low frequency, necessitating the recognition of this spontaneously arising disease when interpreting studies.

Entities:  

Keywords:  interleukin receptor common gamma subunit; lymphoma; mice; murine leukemia viruses; severe combined immunodeficiency

Mesh:

Substances:

Year:  2019        PMID: 31736441      PMCID: PMC8686194          DOI: 10.1177/0300985819882631

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  68 in total

1.  Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.

Authors:  Alice M Coughlan; Cathal Harmon; Sarah Whelan; Eóin C O'Brien; Vincent P O'Reilly; Paul Crotty; Pamela Kelly; Michelle Ryan; Fionnuala B Hickey; Cliona O'Farrelly; Mark A Little
Journal:  Stem Cells Dev       Date:  2016-04-01       Impact factor: 3.272

2.  Gene therapy: X-SCID transgene leukaemogenicity.

Authors:  Adrian J Thrasher; H Bobby Gaspar; Christopher Baum; Ute Modlich; Axel Schambach; Fabio Candotti; Makoto Otsu; Brian Sorrentino; Linda Scobie; Ewan Cameron; Karen Blyth; Jim Neil; Salima Hacein-Bey Abina; Marina Cavazzana-Calvo; Alain Fischer
Journal:  Nature       Date:  2006-09-21       Impact factor: 49.962

3.  Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma.

Authors:  S Ristevski; D F Purcell; J Marshall; D Campagna; S Nouri; S P Fenton; D A McPhee; G Kannourakis
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Lymphomas and high-level expression of murine leukemia viruses in CFW mice.

Authors:  L Taddesse-Heath; S K Chattopadhyay; D L Dillehay; M R Lander; Z Nagashfar; H C Morse; J W Hartley
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Pathology of Aging in NOD scid gamma Female Mice.

Authors:  Sara F Santagostino; Rodolfo J Ricart Arbona; Melissa A Nashat; Julie R White; Sebastien Monette
Journal:  Vet Pathol       Date:  2017-03-29       Impact factor: 2.221

6.  DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.

Authors:  Sonia Minuzzo; Valentina Agnusdei; Irene Pusceddu; Marica Pinazza; Lidia Moserle; Massimo Masiero; Elisabetta Rossi; Marika Crescenzi; Timothy Hoey; Maurilio Ponzoni; Alberto Amadori; Stefano Indraccolo
Journal:  Carcinogenesis       Date:  2014-10-29       Impact factor: 4.944

7.  Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.

Authors:  Robin Jeannet; Jérôme Mastio; Alejandra Macias-Garcia; Attila Oravecz; Todd Ashworth; Anne-Solen Geimer Le Lay; Bernard Jost; Stéphanie Le Gras; Jacques Ghysdael; Thomas Gridley; Tasuku Honjo; Freddy Radtke; Jon C Aster; Susan Chan; Philippe Kastner
Journal:  Blood       Date:  2010-09-09       Impact factor: 22.113

8.  Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice.

Authors:  R Araki; A Fujimori; K Hamatani; K Mita; T Saito; M Mori; R Fukumura; M Morimyo; M Muto; M Itoh; K Tatsumi; M Abe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Bethesda proposals for classification of lymphoid neoplasms in mice.

Authors:  Herbert C Morse; Miriam R Anver; Torgny N Fredrickson; Diana C Haines; Alan W Harris; Nancy L Harris; Elaine S Jaffe; Scott C Kogan; Ian C M MacLennan; Paul K Pattengale; Jerrold M Ward
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

10.  Cell competition is a tumour suppressor mechanism in the thymus.

Authors:  Vera C Martins; Katrin Busch; Dilafruz Juraeva; Carmen Blum; Carolin Ludwig; Volker Rasche; Felix Lasitschka; Sergey E Mastitsky; Benedikt Brors; Thomas Hielscher; Hans Joerg Fehling; Hans-Reimer Rodewald
Journal:  Nature       Date:  2014-05-14       Impact factor: 49.962

View more
  3 in total

Review 1.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

2.  Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors.

Authors:  Heather Tillman; Peter Vogel; Tiffani Rogers; Walter Akers; Jerold E Rehg
Journal:  Vet Pathol       Date:  2020-03-23       Impact factor: 2.221

3.  The HROC-Xenobank-A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models.

Authors:  Stephanie Matschos; Florian Bürtin; Said Kdimati; Mandy Radefeldt; Susann Krake; Friedrich Prall; Nadja Engel; Mathias Krohn; Bianca Micheel; Michael Kreutzer; Christina Susanne Mullins; Michael Linnebacher
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.